Lead Product(s) : Disodium Hydrogen Phosphate
Therapeutic Area : Nephrology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
American Regent Introduces Sodium Phosphates Injection, USP; FDA-Approved and "AP" Rated¹
Details : Sodium Phosphate is an approved small molecule, indicated as a source of phosphorous, for addition to large volume IV fluids, to prevent hypophosphatemia in patients with restricted or no oral intake.
Product Name : Sodium Phosphate-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 07, 2024
Lead Product(s) : Disodium Hydrogen Phosphate
Therapeutic Area : Nephrology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
